Injected form of Leqembi appears effective at clearing amyloid, but with notable risks
New data on an injectable form of Eisai’s Alzheimer’s drug, Leqembi, showed that it was more effective than an intravenous version at clearing amyloid but …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
